paclitaxel has been researched along with Carotid Arteriopathies, Traumatic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; Liu, M; Liu, S; Long, J; Tan, W; Tang, F; Yang, J; Zeng, O | 1 |
| E, Y; Fan, H; He, N | 1 |
| Cho, MC; Kim, DW; Kim, MS; Kim, YG; Kwon, JS; Lee, GS; Youn, TJ | 1 |
| Argentieri, D; Brosius, R; Carter, D; Falotico, R; Parry, TJ; Siekierka, J; Thyagarajan, R | 1 |
| Imai, H; Ingber, DE; Ishii, M; Kondo, T; Kubota, R; Murakami, R; Murohara, T; Numaguchi, Y; Ogawa, Y; Okumura, K; Yokouchi, K | 1 |
| Jin, X; Mei, L; Song, C; Sun, H; Sun, R; Zhang, M; Zhu, D | 1 |
| Che, YZ; Jin, X; Jin, Z; Mei, L; Song, CX; Sun, HF | 1 |
7 other study(ies) available for paclitaxel and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
Gefitinib-coated balloon inhibits the excessive hyperplasia of intima after vascular injuries through PI3K/AKT pathway.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carotid Artery Injuries; Coated Materials, Biocompatible; Gefitinib; Hyperplasia; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Vascular System Injuries | 2019 |
The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty.
Topics: Angioplasty, Balloon; Animals; Biopsy, Needle; Carotid Artery Injuries; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hyperplasia; Immunohistochemistry; Infusions, Intra-Arterial; Male; Neointima; Paclitaxel; Random Allocation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2013 |
Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model.
Topics: Administration, Oral; alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carotid Artery Injuries; Carotid Stenosis; Catheterization; Cell Division; Ethylene Glycols; Glycerol; Hyperplasia; Infusions, Parenteral; Intestines; Linoleic Acids; Male; Models, Animal; Myocytes, Smooth Muscle; Paclitaxel; Pharmaceutical Vehicles; Polysorbates; Radiography; Rats; Rats, Sprague-Dawley; Recurrence; Surface-Active Agents; Tocopherols; Tunica Intima; Verapamil | 2004 |
Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carotid Artery Injuries; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Hyperplasia; Male; Muscle, Smooth, Vascular; Paclitaxel; Rats; Rats, Inbred Lew; Sirolimus; Stents; Tunica Intima | 2005 |
l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
Topics: Angioplasty; Animals; Apoptosis; Calmodulin-Binding Proteins; Carotid Artery Injuries; Catheterization; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Cells, Cultured; Cytoskeleton; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoblotting; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paclitaxel; Protein Isoforms; Rats; Tunica Intima | 2006 |
Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carotid Artery Injuries; Catheterization; Chromatography, High Pressure Liquid; Diffusion; Disease Models, Animal; Endothelium, Vascular; Hyperplasia; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Polyglactin 910; Polyvinyl Alcohol; Rabbits; Solubility; Time Factors; Treatment Outcome; Tunica Intima | 2007 |
[Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carotid Artery Injuries; Catheterization; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Female; Hyperplasia; Lactic Acid; Male; Nanoparticles; Nanotechnology; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Tunica Intima | 2007 |